Health officials are monitoring a new development in the ongoing battle against respiratory illnesses as a new COVID-19 variant spreads across the United States. With confirmed cases now spanning at least 25 states—including New York, Pennsylvania, and Ohio—Western New York residents are encouraged to stay informed on the potential impact of this latest mutation on the Buffalo community and the broader region.
The variant, scientifically designated as BA.3.2, has earned the nickname “Cicada.” This moniker stems from the virus’s ability to remain largely undetected or “underground” since its initial discovery in June 2025. Unlike previous strains that caused immediate, massive surges, the Cicada variant has been quietly gaining a foothold in clinical samples and wastewater surveillance.
Understanding the “Cicada” Impact and Immune Evasion
What sets the Cicada variant apart is a specific mutation that enhances its ability to bypass existing defenses. According to a recent report from the Centers for Disease Control and Prevention (CDC), this strain can effectively avoid antibodies in individuals who have been vaccinated or previously infected by earlier variants. This high level of transmissibility poses a renewed risk for seasonal increases in COVID-19 activity across the Lake Erie region.
Regional and National Spread: States Affected
The CDC has utilized a combination of nasal swabs, clinical samples, and wastewater monitoring to track the variant’s trajectory. As of mid-February, the variant has been identified in half of the U.S. states. For those in the Western New York corridor, the presence of the variant in all neighboring states highlights the necessity of local vigilance.
| Region | States with Confirmed BA.3.2 (Cicada) Cases |
|---|---|
| Northeast/Mid-Atlantic | Connecticut, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont |
| Midwest | Illinois, Michigan, Missouri, Ohio |
| South | Florida, Louisiana, South Carolina, Texas, Virginia |
| West | California, Hawaii, Idaho, Nevada, Utah, Wyoming |
Public Health Concerns and Preparedness
While the broader narrative surrounding the pandemic has shifted, COVID-19 remains a significant public health priority. The 2024-2025 respiratory virus season saw at least 390,000 hospitalizations and 45,000 deaths nationwide. Investigative analysis suggests that mutations like Cicada could exacerbate these figures by targeting vulnerable populations whose immunity may have waned.
“New SARS-CoV-2 variants with substantial capacity to evade immunity from previous infections or vaccines could be associated with seasonal increases in COVID-19 activity,” the CDC stated. The agency continues to emphasize that robust surveillance data will guide future vaccine composition updates and regional preparedness strategies.
At Lake Erie Times, we remain committed to providing our community with accurate, in-depth coverage of health issues affecting the Buffalo area. As William Strasmore continues to track the regional data, we will provide updates on how local healthcare systems are preparing for potential seasonal shifts.
Disclaimer: The content provided by Lake Erie Times is for informational purposes only and should not be considered as professional medical, legal, or financial advice.
Affiliate Disclaimer: Some links on Lake Erie Times are affiliate links. This means that if you make a purchase through these links, we may earn a commission at no additional cost to you. Our recommendations are based on careful research and our commitment to quality journalism.
